Article

Viral and antiretroviral dynamics in HIV mother-to-child transmission fluids (VADICT) – Protocol and data analysis plan for a cohort study

2019-02-18

Abstract excerpt

<h4>Background: </h4> Pregnancy and polymorphisms in drug disposition genes alter the clearance of key antiretrovirals used as part of regimens for prevention of mother-to-child transmission of HIV (PMTCT). The clinical significance of these in women initiating therapy late in pregnancy has not been investigated. The primary objective of the Viral and Antiretroviral Dynamics in HIV Mother-To-Child Transmission Flu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b75a6470-5a3a-51fe-a59b-204571b1f868
DOI: 10.12688/wellcomeopenres.15072.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Viral and antiretroviral dynamics in HIV mother-to-child transmission fluids (VADICT) – Protocol and data analysis plan for a cohort studyDOI 10.12688/wellcomeopenres.15072.1Read

Pharmacogenetics of efavirenz exposure in cervicovaginal fluid during pregnancy and postpartumSemantic proximity Read

Pharmacogenetics of Efavirenz Exposure in Cervicovaginal Fluid during Pregnancy and Postpartum.Semantic proximity Read

Breastmilk transfer of cabotegravir and infant safety outcomes in mothers on cabotegravir for HIV prevention in Lilongwe, Malawi: A protocol for an observational pharmacokinetic study, CABMILK StudySemantic proximity Read

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding.Semantic proximity Read

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVSemantic proximity Read

Viral Suppression and Resistance in a Cohort of Perinatally-HIV Infected (PHIV+) Pregnant Women.Semantic proximity Read

Longitudinal Analysis of Viral Suppression Before, During, and After Pregnancy Among Women on Antiretroviral Therapy in Uganda: Six-year Real-World EvidenceSemantic proximity Read

Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion ExperimentsSemantic proximity Read

Population pharmacokinetics of lumefantrine in pregnant and non-pregnant Nigerian women receiving efavirenz-based antiretroviral therapy.Semantic proximity Read

Relating CYP2B6 Genotype and EFV Resistance Among Women Living With HIV With High Viremia in Uganda: A Nested Cross-Sectional Study.Semantic proximity Read

Host Factors that Influence Mother-to-Child Transmission of HIV-1: Genetics, Coinfections, Behavior and NutritionSemantic proximity Read